🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

PRPO PRPO

Company Profile ↓
$23.48
+61.82% 1Y
Mkt Cap$41.82M
P/E-102.09
P/B2.87
52W High$32.37
52W Low$13.80
Book Value$8.18
EPS (TTM)$-0.23

Company Overview

PRPO (PRPO) is a publicly traded company listed on with a market capitalization of $41.82M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.25.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Dec 2025 Revenue of $24.05M (+29.8% YoY); net profit $-363.00K.
  • Trailing 12 Months Year-on-year growth — revenue +29.8%.
  • 5-Year Trend Long-term compounding — revenue CAGR 0.6%.

Growth & Price Performance

Compounded Sales Growth

5 Years:0.59%
1 Year:29.77%

Stock Price Performance

1 Year:+61.82%
6 Months:-3.17%
3 Months:-27.46%
1 Month:-9.69%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Mixed
52-Week Range 52% of range
$13.80 $32.37
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMABelow
  • RSI (14)50.98 · Neutral
Price Performance
1M-9.69%
3M-27.46%
6M-3.17%
1Y+61.82%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Generates positive free cash flow.

CONS

  • Trading 27.5% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-102.09
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$8.18
Price to Book
2.87
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
0.59%
Profit 5Y
-
Revenue (YoY)
29.77%
Earnings (YoY)
-

Profitability & Returns

ROCE
-6.84%
ROE
-2.49%
ROA
-1.70%
Profit Margin
-1.51%
Op Margin
-5.00%
Gross Margin
44.52%
EPS (Latest Qtr)
$-0.81
EPS (TTM)
$-0.23

Balance Sheet & Liquidity

Debt/Equity
0.25
Quick Ratio
1.36
Current Ratio
1.61
Debt
$3.65M
Total Assets
$20.80M
Current Assets
$5.93M
Working Capital
$2.29M

Ownership

Promoter Holding
12.65%
Chg in Prom Hold
0.00%
FII / Inst Holding
17.69%
Chg in FII Hold
0.00%

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$24.05M
EBITDA
$1.46M
Free Cash Flow
$359.00K
Operating Cash Flow
$685.00K
Shares Outstanding
1.78M
Gross Margin
44.52%
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Dec 2013Mar 2014Jun 2014Sep 2014Dec 2014Mar 2015Jun 2015Sep 2015Mar 2016Jun 2016Sep 2016Mar 2017Jun 2017Sep 2017Mar 2018Jun 2018Sep 2018Mar 2019Jun 2019Sep 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue --------------796.00K959.00K823.00K917.00K1.20M1.05M1.48M1.65M2.05M2.11M2.24M2.14M2.53M2.45M2.29M2.83M3.65M4.57M3.48M4.51M5.28M4.93M5.65M6.77M6.70M6.71M
Cost of Revenue -----------------------------------2.79M3.23M3.76M3.57M3.99M
Gross Profit 2.08M2.49M2.39M1.72M2.62M285.00K-23.00K-115.00K-269.00K263.00K134.00K66.00K-24.00K-77.00K24.00K175.00K-11.00K38.00K172.00K28.00K125.00K171.00K377.00K468.00K751.00K528.00K703.00K773.00K436.00K749.00K1.37M1.89M920.00K1.72M2.28M2.14M2.43M3.00M3.13M2.73M
Operating Expenses -----------------------------------3.00M3.25M3.07M2.59M4.15M
Operating Income --3.54M-3.96M-3.99M--1.97M-2.40M-2.26M-2.24M-285.00K-363.00K-596.00K-801.00K-3.63M-2.45M-2.18M-4.12M-2.06M-2.29M-2.36M-2.20M-2.26M-2.43M-2.14M-2.13M-2.44M-4.81M-2.43M-3.23M-3.03M-2.29M-1.45M-2.07M-1.21M-597.00K-859.00K-824.00K-61.00K542.00K-1.43M
EBITDA ------------------------------------442.00K519.00K367.00K1.02M-971.00K
Interest Expense -----------------------------------25.00K23.00K9.00K16.00K15.00K
Pretax Income ------------------------------------884.00K74.00K-79.00K526.00K-1.44M
Tax Provision -----------------------------------00000
Net Income -3.98M-4.18M-3.89M-80.00K-5.79M-3.04M-3.27M-7.30M-3.26M-444.00K-499.00K-758.00K-3.68M-6.28M-2.44M-2.83M-3.85M-1.65M-5.91M-1.90M-3.21M---------------884.00K74.00K-79.00K526.00K-1.44M
Diluted EPS ------------------------0.08-0.14-0.08-0.20-0.09-2.79-2.61-1.88-1.04-1.46-0.83-0.42-0.590.05-0.05--0.81
R&D Expense -745.00K785.00K641.00K-451.00K468.00K455.00K270.00K402.00K393.00K134.00K----------------------------

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue 22.02M20.05M31.97M31.48M27.54M1.24M1.93M1.72M2.03M3.45M4.09M7.43M-9.41M15.20M18.53M24.05M
Cost of Revenue -------------6.90M9.18M10.97M13.34M
Gross Profit 11.61M9.76M18.44M13.13M10.75M-935.00K-11.00K753.00K292.00K225.00K219.00K1.15M-2.51M6.02M7.56M10.71M
Operating Expenses -------------15.31M13.64M11.78M11.91M
Operating Income -1.90M-3.61M-2.97M-9.50M-15.76M-10.57M-8.92M-1.71M-15.51M-13.91M-10.99M-9.15M--12.80M-7.62M-4.22M-1.20M
EBITDA --------------10.65M-4.32M-2.70M1.46M
Interest Expense -------------12.00K18.00K74.00K73.00K
Pretax Income --------------12.18M-5.85M-4.29M-363.00K
Tax Provision -------------0000
Net Income -1.92M-3.13M-9.78M-8.33M-15.99M-13.94M-32.95M-2.23M-20.69M-15.69M-13.24M-13.97M--12.20M-5.85M-4.29M-363.00K
Diluted EPS ------------0.85--10.73-4.51-2.93-0.23
R&D Expense 3.18M2.31M2.22M2.49M3.21M2.25M1.85M0500.00K1.10M1.20M1.20M1.30M1.70M1.70M1.30M1.60M

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --32.03M33.56M38.79M30.28M30.01M4.82M842.00K27.26M21.61M19.51M20.71M-21.50M18.10M17.00M21.32M
Current Assets --------------5.71M3.68M3.45M6.04M
Cash & Equivalents 4.77M5.64M3.45M4.95M4.50M1.63M1.61M235.00K51.00K421.00K381.00K848.00K2.66M-3.44M1.50M1.39M2.65M
Inventory --------------708.00K384.00K724.00K935.00K
Receivables --------------1.04M1.30M799.00K1.98M
Total Liabilities --22.07M22.51M18.52M18.83M23.45M17.64M7.30M14.23M15.48M6.31M6.55M-5.14M3.67M4.90M6.76M
Current Liabilities --8.25M16.33M15.27M8.62M11.99M16.98M3.01M10.04M13.77M4.33M4.66M-4.36M3.14M4.27M3.75M
Long Term Debt --8.64M4.94M06.32M7.38M04.13M2.83M253.00K198.00K362.00K-134.00K106.00K77.00K47.00K
Total Debt --------------1.39M1.12M1.25M3.65M
Total Equity 13.21M11.66M8.50M11.05M20.27M11.45M6.55M-2.10M-6.46M13.03M6.12M13.21M14.13M-16.30M14.43M12.09M14.56M
Shares Outstanding --------------1.14M1.42M1.49M1.78M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow 1.27M-1.72M220.00K-10.20M-8.47M-13.70M-12.38M-959.00K-6.69M-6.75M-9.14M-7.43M--7.72M-3.56M439.00K685.00K
Investing Cash Flow -377.00K-6.23M-508.00K-4.88M-1.77M3.62M1.79M1.01M-42.00K-97.00K-55.00K-96.00K--277.00K-126.00K-223.00K-326.00K
Financing Cash Flow 05.76M1.73M14.60M7.37M10.07M8.99M775.00K7.10M6.81M9.66M9.34M--225.00K1.74M-329.00K903.00K
Capital Expenditure -351.00K-192.00K-231.00K-882.00K-605.00K-130.00K-204.00K-19.00K-143.00K-97.00K-55.00K-151.00K--277.00K-126.00K-223.00K-326.00K
Free Cash Flow 916.00K-1.91M-11.00K-11.09M-9.08M-13.83M-12.58M-978.00K-6.83M-6.85M-9.20M-7.58M--8.00M-3.69M216.00K359.00K
Net Change in Cash --------------8.22M-1.94M-113.00K1.26M

Ratios (Annual)

Figures in %.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % 52.7%48.7%57.7%41.7%39.0%-75.4%-0.6%43.7%14.4%6.5%5.3%15.5%-26.7%39.6%40.8%44.5%
Operating Margin % -8.6%-18.0%-9.3%-30.2%-57.2%-852.3%-462.4%-99.4%-763.0%-403.5%-268.5%-123.1%--136.0%-50.1%-22.7%-5.0%
Net Margin % -8.7%-15.6%-30.6%-26.5%-58.0%-1,124.4%-1,708.3%-129.3%-1,017.9%-455.2%-323.4%-188.0%--129.7%-38.5%-23.1%-1.5%
ROE % -16.5%-36.9%-88.5%-41.1%-139.7%-212.8%1,571.5%34.5%-158.9%-256.3%-100.3%-98.8%--74.9%-40.6%-35.5%-2.5%
ROCE % --15.2%-17.2%-40.4%-72.8%-58.7%73.3%78.9%-90.1%-177.4%-72.4%-57.0%--74.6%-50.9%-33.1%-6.8%

Shareholding Pattern

Insiders
12.65%
Institutions
17.69%
Public Float
20.26%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for PRPO

Yahoo Finance Fri, 12 Jun 2026

Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting

NEW HAVEN, Conn., June 12, 2026 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) is requesting that shareholders instruct their brokers to vote their shares immediately. Votes must be rece…

Yahoo Finance hu, 11 Jun 2026

Precipio to Present at the Planet MicroCap Las Vegas

NEW HAVEN, Conn., June 11, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces that it will be presenting at the Planet MicroCap Las Vegas 2026 on Wednesday, June 17, 2026, at 9:00 AM (Loca…

Yahoo Finance ue, 02 Jun 2026

Precipio (PRPO) Q1 2026 Earnings Call Transcript

Ilan Danieli: Good afternoon, everyone, and thank you for joining us today for Precipio's Q1 2026 Shareholder Update Call. Before reviewing the quarterly financials for Q1, I'd like to take a moment to step back and discuss where we believ…

Yahoo Finance hu, 21 May 2026

Precipio Inc (PRPO) Q1 2026 Earnings Call Highlights: Revenue Growth Amidst Margin Challenges

Precipio Inc (PRPO) reports a 30% year-over-year revenue increase, while facing margin pressures and a negative EBITDA in Q1 2026.

Yahoo Finance hu, 14 May 2026

Precipio Announces Q1 2026 Financial Results

Stable revenue performance driven by timing dynamics; expanding product pipeline expected to drive second-half growthNEW HAVEN, Conn., May 14, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), anno…

Yahoo Finance Mon, 11 May 2026

B2i Digital Welcomes Precipio, Inc. as a New Featured Company

Specialty Cancer Diagnostics Company Focused on Creating Cutting-Edge Products for Laboratories Through a Unique Business Model FY 2025 Revenue Grew 30% to $24.0 Million; Gross Margin Expanded to 45%; Achieved Cash Flow Positive in Q4-2025 …

PRPO — Frequently Asked Questions

What is the current share price of PRPO?

As of 2026-08-05 17:25 PDT, PRPO trades at $23.48 on NASDAQ/NYSE. Its 52-week range is $13.80 to $32.37.

What is the market capitalisation of PRPO?

PRPO has a market capitalisation of $41.82M on NASDAQ/NYSE.

What is the P/E ratio of PRPO?

PRPO trades at a trailing price-to-earnings (P/E) ratio of -102.09. Its price-to-book (P/B) ratio is 2.87.

What is the return on equity (ROE) of PRPO?

PRPO has a return on equity (ROE) of -2.49%. Its return on capital employed (ROCE) is -6.84%.

Is PRPO a good stock to buy?

This page provides a data-driven analysis of PRPO, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space